Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1488039 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $2.31Day −4.35%Mkt cap $20M1Y −83.2%Off 52W high −88.0%Vol (1Y) 88.4%
Daily closing price, split-adjusted to the current basis; 3y shown of 3,432 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest9.0% of sh out |
| Days to cover4.7d |
| Top-10 13F concentration97.9% |
| Next report (est.)2026-08-07 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$37.6M |
| ROE−62.7% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−73.9% |
| 1Y−83.2% |
| 3Y−86.0% |
| 5Y−96.0% |
| 10Y−38.6% |
| Since incept. (ann.)−22.2% |
Price return through 2026-07-29 · series begins 2012-11-08. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)88.4% |
| Ann. volatility (3Y)74.9% |
| Sharpe (1Y)−1.39 |
| Sharpe (3Y)−0.49 |
| Max drawdown (1Y)−90.1% |
| Max drawdown (3Y)−94.4% |
| Beta (3Y vs SPY)1.51 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 349,096 | $2M | 4.05% | new |
| AMERIPRISE FINANCIAL INC | 255,134 | $1M | 2.96% | −93.3% |
| BlackRock, Inc. | 133,169 | $700,469 | 1.55% | −93.3% |
| RENAISSANCE TECHNOLOGIES LLC | 109,007 | $573,377 | 1.27% | −94.7% |
| GEODE CAPITAL MANAGEMENT, LLC | 97,061 | $510,657 | 1.13% | −92.9% |
| UBS Group AG | 92,034 | $484,099 | 1.07% | −76.4% |
| MILLENNIUM MANAGEMENT LLC | 66,739 | $351,047 | 0.78% | −94.6% |
| VANGUARD FIDUCIARY TRUST CO | 52,235 | $274,756 | 0.61% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-08 | −$1.11 | — | — | — |
| 2025-09-30 | 2025-11-12 | — | — | — | — |
| 2025-06-30 | 2025-08-12 | — | — | — | — |
| 2025-03-31 | 2025-05-13 | — | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-07 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
